NCT01846416 · Interventional trial
A Study of Atezolizumab in Participants With Programmed Death-Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [FIR]
Overall registry status Completed
Phase 2
Conditions Non-Small Cell Lung Cancer
Delaware Valley sites
- Penn Presbyterian Medical Center; Abramson Cancer Center · Philadelphia, PA · Philadelphia County
- University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory